A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Clinical trial NCT01931670 · COMPLETED
Trial details
- NCT number
- NCT01931670
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-09
- Primary completion
- 2016-01-06
- Enrollment
- 815
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.